Alibaba Health shares jumped 12% in Hong Kong.
Alibaba Health and Novo Nordisk have partnered to launch a digital platform for weight and chronic disease management. The service integrates medical education, AI-driven tools, and delivery solutions to support early screening and treatment of obesity and diabetes, in line with China’s public health initiatives.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。